Early research suggests a new nasal spray vaccine could protect against multiple respiratory threats.

The vaccine could replace the need for separate annual jabs for flu, Covid and cold viruses as well as providing defence ...

If approved, mCOMBRIAX would become the first combination Covid-flu jab to gain regulatory approval anywhere across the globe ...

European regulators cleared Moderna’s first-of-its-kind vaccine as US approval remains uncertain. On Friday, Moderna’s ...

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) Feb ...

In issuing a positive recommendation, the EMA has diverged from the FDA, which has set higher approval standards for ...

European regulators advanced several new medicines, including a combined flu and COVID vaccine and new treatments for rare diseases.

Moderna has managed to eke out some temporary wins, paving the way for the homegrown biotech to focus on its next moves.

Experts at Stanford Medicine in the US have developed a universal vaccine that could be given as a nasal spray and could ...

A single-dose multicomponent mRNA vaccine elicits durable immune responses against influenza and COVID-19 in a Phase 1/2 trial.

The European Medicines Agency (EMA) announced Friday it has recommended Moderna’s combined mRNA COVID-19 and flu vaccine be ...

Flu has overtaken covid in infections and hospitalizations during the winter respiratory virus season, and their virulence is ...